Literature DB >> 2205183

Accuracy of diagnosis of choroidal melanomas in the Collaborative Ocular Melanoma Study. COMS report no. 1.

.   

Abstract

In the 3-year period during which patients were enrolled into the Collaborative Ocular Melanoma Study, 413 eyes with clinical diagnoses of choroidal melanoma were examined histopathologically as of December 31, 1989. Four hundred eleven of these eyes were found to be diagnosed correctly. One eye, removed after preoperative external beam radiation, was found to have a hemangioma. The second eye, removed after radioactive iodine plaque placement, was described as a magnocellular nevus (melanocytoma) by four of the five pathologists on the Collaborative Ocular Melanoma Study Pathology Review Committee. The Collaborative Ocular Melanoma Study misdiagnosis rate of 0.48% is the lowest ever reported. The major challenge with regard to posterior uveal melanomas is no longer that of correct diagnosis but rather determination of the optimal treatment.

Entities:  

Mesh:

Year:  1990        PMID: 2205183     DOI: 10.1001/archopht.1990.01070110084030

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  52 in total

1.  Digital imaging in differential diagnosis of small choroidal melanoma.

Authors:  Jukka M Saari; Tero Kivelä; Paula Summanen; Kari Nummelin; K Matti Saari
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

2.  The molecular classification of uveal melanocytic lesions: an important discovery in context.

Authors:  Robert Folberg
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

3.  Ultrasound biomicroscopy in the management of melanocytoma of the ciliary body with extrascleral extension.

Authors:  M D Mohamed; M Gupta; A Parsons; I G Rennie
Journal:  Br J Ophthalmol       Date:  2005-01       Impact factor: 4.638

4.  Association between traditional clinical high-risk features and gene expression profile classification in uveal melanoma.

Authors:  Brandon T Nguyen; Ryan S Kim; Maria E Bretana; Eric Kegley; Amy C Schefler
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-28       Impact factor: 3.117

5.  Proton therapy for uveal melanomas and other eye lesions.

Authors:  J E Munzenrider
Journal:  Strahlenther Onkol       Date:  1999-06       Impact factor: 3.621

6.  Optic Disc Pyogenic Granuloma.

Authors:  Eduardo F Marback; Luciano Espinheira Fonseca; Roberto L Marback
Journal:  Ocul Oncol Pathol       Date:  2016-11-09

7.  Uveal melanoma: quantitative evaluation of diffusion-weighted MR imaging in the response assessment after proton-beam therapy, long-term follow-up.

Authors:  Pietro Valerio Foti; Antonio Longo; Michele Reibaldi; Andrea Russo; Giuseppe Privitera; Corrado Spatola; Luigi Raffaele; Vincenzo Salamone; Renato Farina; Stefano Palmucci; Andrea Musumeci; Rosario Caltabiano; Marco Ragusa; Cesare Mariotti; Teresio Avitabile; Pietro Milone; Giovanni Carlo Ettorre
Journal:  Radiol Med       Date:  2016-10-17       Impact factor: 3.469

8.  Reduced expression of autotaxin predicts survival in uveal melanoma.

Authors:  Arun D Singh; Karen Sisley; Yaomin Xu; Jianbo Li; Pieter Faber; Sarah J Plummer; Hardeep S Mudhar; Ian G Rennie; Patricia M Kessler; Graham Casey; Bryan G Williams
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

9.  Clinical imaging and high-resolution ultrasonography in melanocytoma management.

Authors:  Daniel Gologorsky; Amy C Schefler; Fiona J Ehlies; Paul A Raskauskas; Yolanda Pina; Basil K Williams; Timothy G Murray
Journal:  Clin Ophthalmol       Date:  2010-08-09

10.  HIC1 modulates uveal melanoma progression by activating lncRNA-numb.

Authors:  Guangcun Cheng; Jie He; Leilei Zhang; Shengfang Ge; He Zhang; Xianqun Fan
Journal:  Tumour Biol       Date:  2016-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.